作者: S. Singla , S. Gupta , R. M. Reddy , P. Durgapal , C. S. Bal
DOI: 10.1093/JJCO/HYS172
关键词: Radiology 、 Radionuclide therapy 、 DOTA 、 Neuroendocrine tumors 、 Peptide receptor 、 Octreotide 、 Receptor 、 Somatostatin receptor 、 Medicine 、 Positron emission tomography
摘要: The management of neuroendocrine tumours is challenging when curative surgery ruled out because distant metastases. We report a case gastrointestinal carcinoid with bilateral ovarian metastases in 50-year-old female who received octreotide therapy followed by peptide receptor radionuclide and thereafter. Somatostatin expression on has implications diagnosis therapy. (68)Ga-DOTA-NOC PET recent advancement the field somatostatin imaging. lesions which demonstrate tracer uptake positron emission tomographic studies can be further planned for treatment (177)Lu-DOTA-TATE. discussion responded well to non-invasive options before proceeding definitive surgical management.